Diabetes Clinical Trials in Seattle

Showing 41-60 of 375 trials

Omnipod 5 System Compared to Pump Therapy

NCT05409131

Subject will undergo a 14-day outpatient, standard therapy phase during which sensor and insulin data will be collected. This will be followed by a 90-day outpatient phase where subjects will either use the Omnipod 5 system or continue to use their personal insulin pump with the study provided continuous glucose monitoring system. Participants in France will be offered an optional extension of 12 months of Omnipod 5 System use.

Type 1 Diabetes

Insulet Corporation196 participantsStarted Jul 2022

Palo Alto, California, United States • Santa Barbara, California, United States • Denver, Colorado, United States +11 more locations

RECRUITINGPhase 2< 1 mile

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

NCT05822609

The primary objective of this study is to determine the effects of semaglutide on kidney oxygenation and function in type 1 diabetes. The secondary objective is to determine the glycemic effects and safety of semaglutide in type 1 diabetes.

Diabetic Kidney DiseaseType 1 Diabetes

University of Washington60 participantsStarted Apr 2024

Aurora, Colorado, United States • Seattle, Washington, United States • Spokane, Washington, United States +1 more locations

Omnipod 5 System Compared to Pump Therapy

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

Diabetes Trials in Other Cities

The Diabetes Prevention Program Outcomes Study AD/ADRD Project

Afrezza® INHALE-1 Study in Pediatrics

Patient Specific 3D Printed Diabetic Insoles to Reduce Plantar Pressure

AI Ready and Exploratory Atlas for Diabetes Insights

Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)

Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)

Efficacy, Safety, and PK of LX9211 in Participants With Diabetic Peripheral Neuropathic Pain

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy

Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin

HbA1c Variation Study

A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections

A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to <18 Years) With Type 2 Diabetes Mellitus

A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

Other Conditions in Seattle